Archive for 2009

What is MHRA?

The MHRA (Medicines and Healthcare Products Regulatory Agency) was set up by the UK Government in April 2003 from a merger of the Medicines Control Agency and the Medical Devices Agency. The MHRA is the governmental agency responsible for standards of safety, quality and performance.
(more…)

The Bar Code Celebrates its 57th Birthday!

7th October 2009 – is the anniversary of the first patent on the bar code. Inventors Norman Woodland and Bernard Silver filed the patent on October 1949, and it was granted #2,612,994 on October 7, 1952. The original patent was for a system that would encode data in circles (a bulls eye pattern), so that it could be scanned in any direction and was first created for use on train carriages. (more…)

GS1 – Increase Efficiency, Reduce Costs & Increase Patient Safety

GS1 adoption is vital as life sciences and healthcare companies focus on reducing operating costs and increasing efficiency. Software companies are rising to the challenge as the life sciences industries focus on reducing operating costs and increasing efficiency in these tough economic times.

Threat From Generics Increases Brand Focus

As pressure from generics increases, companies are starting to appreciate the value of brand loyalty.  There will always be some consumers that buy on price but for many a name you can trust is still important.  (more…)

GS1 – Reduce Costs, Increase Efficiency & Improve Patient Safety

GS1 adoption is vital as life sciences and healthcare companies focus on reducing operating costs, increasing efficiency and improving patient safety. Software companies are rising to the challenge as the life sciences and healthcare industries focus on reducing operating costs and increasing efficiency in these tough times. (more…)

21 CFR Part 11 Labeling Systems

Everyone in the biotech and life sciences industries knows that 21 CFR Part 11 is not a new requirement ‘ it dates back to 1997, and has remained pretty much unchanged since then. Only its scope has changed.

Initially, the new requirement was widely ignored by both the industry and the FDA. This indifference was not intentional, but can be attributed to a pure lack of understanding by both the industry and the regulators. (more…)